首页 > 最新文献

Integrative cancer science and therapeutics最新文献

英文 中文
APE1/Ref-1 with reducing activity induces mesenchymal-to-epithelial transition in TNF-α-stimulated breast cancer cells 具有还原活性的APE1/Ref-1在TNF-α刺激的乳腺癌细胞中诱导间质向上皮转化
Pub Date : 2022-01-01 DOI: 10.15761/icst.1000365
Sunga Choi, Ki Mo Kim, Euna Choi
{"title":"APE1/Ref-1 with reducing activity induces mesenchymal-to-epithelial transition in TNF-α-stimulated breast cancer cells","authors":"Sunga Choi, Ki Mo Kim, Euna Choi","doi":"10.15761/icst.1000365","DOIUrl":"https://doi.org/10.15761/icst.1000365","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Exploiting mechanism-informed phenotypic screening for development of next-generation antimitotic phytochemicals 利用机制知情的表型筛选开发下一代抗有丝分裂植物化学物质
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000350
Namrta Choudhry, Thaddeus David Allen, Vidhula R. Ahire, Jing Zhang, Dun Yang
in the CNS and therapeutic resistance which are repetitively seen at the time of microtubule-targeting, the use of these drugs is limited [1-4]. The new generation of mitotic drugs aims for the mitotic regulatory machinery which involves the motor proteins, mitotic kinesins, or the Aurora and polo-like kinases and complexes which are expressed only at the time of cell division [2]. Research efforts are intended towards developing superior antimitotic drugs that would not be only more specific in their action but would also lessen the burden of side effects on patients. Also, because cancer cells demonstrate vast phenotypic miscellany they are characteristically responsive to phenotypic screening which would assist in translating the molecular mechanism as a therapeutic approach in treating cancer with familiar cellular phenotypes following the theory of mechanism-informed phenotypic screening.
在微管靶向时反复出现的中枢神经系统疾病和治疗耐药,这些药物的使用受到限制[1-4]。新一代有丝分裂药物的目标是有丝分裂调节机制,包括运动蛋白,有丝分裂激酶,或仅在细胞分裂时表达的Aurora和polo样激酶和复合物。研究工作的目的是开发更好的抗有丝分裂药物,这些药物不仅在作用上更具体,而且还能减轻患者的副作用负担。此外,由于癌细胞表现出巨大的表型多样性,它们对表型筛选具有特征性反应,这将有助于将分子机制翻译为一种治疗方法,根据机制知情的表型筛选理论,治疗具有熟悉细胞表型的癌症。
{"title":"Exploiting mechanism-informed phenotypic screening for development of next-generation antimitotic phytochemicals","authors":"Namrta Choudhry, Thaddeus David Allen, Vidhula R. Ahire, Jing Zhang, Dun Yang","doi":"10.15761/icst.1000350","DOIUrl":"https://doi.org/10.15761/icst.1000350","url":null,"abstract":"in the CNS and therapeutic resistance which are repetitively seen at the time of microtubule-targeting, the use of these drugs is limited [1-4]. The new generation of mitotic drugs aims for the mitotic regulatory machinery which involves the motor proteins, mitotic kinesins, or the Aurora and polo-like kinases and complexes which are expressed only at the time of cell division [2]. Research efforts are intended towards developing superior antimitotic drugs that would not be only more specific in their action but would also lessen the burden of side effects on patients. Also, because cancer cells demonstrate vast phenotypic miscellany they are characteristically responsive to phenotypic screening which would assist in translating the molecular mechanism as a therapeutic approach in treating cancer with familiar cellular phenotypes following the theory of mechanism-informed phenotypic screening.","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Putative oncogenic viruses: Some data on Brazilian subjects 假定的致癌病毒:巴西受试者的一些数据
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000358
Bernardo G Tenorio, Isadora S Bretas, Joao PRA Bernardes, Munnah NJ Mansour, Sarah MS Napoleao, Sheyla AS Rocha, Thatiane L Sampaio, Elisiario CV Leitao, Joaquim X Silva, Marcus VS Coimbra, Edson JM Bello, Elida CGM Kanzaki, I. Kanzaki
{"title":"Putative oncogenic viruses: Some data on Brazilian subjects","authors":"Bernardo G Tenorio, Isadora S Bretas, Joao PRA Bernardes, Munnah NJ Mansour, Sarah MS Napoleao, Sheyla AS Rocha, Thatiane L Sampaio, Elisiario CV Leitao, Joaquim X Silva, Marcus VS Coimbra, Edson JM Bello, Elida CGM Kanzaki, I. Kanzaki","doi":"10.15761/icst.1000358","DOIUrl":"https://doi.org/10.15761/icst.1000358","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ataxia-telangiectasia 共济失调毛细血管扩张
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000359
A. Ekladious
proneness cancer-predisposing genes present in the population at frequencies affect cancer incidence which do not result in cancer with a high enough probability to give rise to "cancer families." gene predisposing to be associated with the gene for debrizoquine metabolism autosomal recessive for A-T2 in the heterozygous (i.e., carrier) state, Homozygotes for A-T show a rare syndrome with a fascinating variety of aspects. Patients are deficient in immune response, show progressive neurological degeneration and defects in organ maturation, and are prone to develop cancer, particularly of the cells of the immune system Ref. Their cells show spontaneous chromosomal instabilities, and there are reports of hypersensitivity to the chromosome-breaking and/or lethal effect of ionizing radiation and certain chemicals such as bleomycin, neocarzinostatin, Adriamycin, and Hoechst 33342. A further addition to this list is phorbol ester (Shiloh, Boston, MA), a tumor that been cause endogenous
易患癌症的基因存在于人群中,频率影响癌症发病率,但不会导致癌症的高概率产生“癌症家族”。易患与脱苯喹代谢基因相关的基因在杂合子(即携带者)状态下常染色体隐性的a - t2, a - t的纯合子显示出一种罕见的综合征,具有令人着迷的多种方面。患者免疫反应不足,表现为进行性神经退化和器官成熟缺陷,易发生癌症,特别是免疫系统细胞。他们的细胞表现出自发的染色体不稳定性,并且有报道称对电离辐射和某些化学物质如博来霉素、新ocarzinostatin、阿霉素和Hoechst 33342的染色体断裂和/或致死效应过敏。该列表的另一个补充是phorbol ester (Shiloh, Boston, MA),一种内源性肿瘤
{"title":"Ataxia-telangiectasia","authors":"A. Ekladious","doi":"10.15761/icst.1000359","DOIUrl":"https://doi.org/10.15761/icst.1000359","url":null,"abstract":"proneness cancer-predisposing genes present in the population at frequencies affect cancer incidence which do not result in cancer with a high enough probability to give rise to \"cancer families.\" gene predisposing to be associated with the gene for debrizoquine metabolism autosomal recessive for A-T2 in the heterozygous (i.e., carrier) state, Homozygotes for A-T show a rare syndrome with a fascinating variety of aspects. Patients are deficient in immune response, show progressive neurological degeneration and defects in organ maturation, and are prone to develop cancer, particularly of the cells of the immune system Ref. Their cells show spontaneous chromosomal instabilities, and there are reports of hypersensitivity to the chromosome-breaking and/or lethal effect of ionizing radiation and certain chemicals such as bleomycin, neocarzinostatin, Adriamycin, and Hoechst 33342. A further addition to this list is phorbol ester (Shiloh, Boston, MA), a tumor that been cause endogenous","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of low doses of verapamil on the course of Kaposi's sarcoma 低剂量维拉帕米对卡波西肉瘤病程的影响
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000362
Gridina Nina Yakivna
{"title":"The effect of low doses of verapamil on the course of Kaposi's sarcoma","authors":"Gridina Nina Yakivna","doi":"10.15761/icst.1000362","DOIUrl":"https://doi.org/10.15761/icst.1000362","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67479077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial comments to the articles published in Volume 8 对第8卷发表的文章的评论
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000363
H. Miyamoto
{"title":"Editorial comments to the articles published in Volume 8","authors":"H. Miyamoto","doi":"10.15761/icst.1000363","DOIUrl":"https://doi.org/10.15761/icst.1000363","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular characterization of prevalence, serotypes, virulence factors, and antibiotic resistance of Streptococcus agalactiae in a maternity hospital, Iran 伊朗一家妇产医院无乳链球菌患病率、血清型、毒力因子和抗生素耐药性的分子特征
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000356
Shokouh Sadat Aboutorabi, Z. Rasooli, H. Pakniat, Fahimeh Baloo
{"title":"Molecular characterization of prevalence, serotypes, virulence factors, and antibiotic resistance of Streptococcus agalactiae in a maternity hospital, Iran","authors":"Shokouh Sadat Aboutorabi, Z. Rasooli, H. Pakniat, Fahimeh Baloo","doi":"10.15761/icst.1000356","DOIUrl":"https://doi.org/10.15761/icst.1000356","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67479013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Prospects for colorectal cancer prevention targeting intestinal microbiome 以肠道微生物组为靶点预防结直肠癌的研究前景
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000351
T. Ohara
Received: January 03, 2021; Accepted: January 26, 2021; Published: January 29, 2021 It has been reported that a so-called clean colon procedure, in which all precancerous lesions, colorectal tubular adenomas / colorectal tubulovillous adenomas, are endoscopically resection treatment is extremely useful for preventing colorectal carcinogenesis and death from colorectal cancer [1-4]. The effectiveness of chemopreventive measures to take the antidiabetic drugs metformin and low-dose aspirin has also been reported [5-7]. Recently, there have been reports suggesting the involvement of intestinal microorganisms such as Fusobacterium nucleatum (F. nucleatum) in colorectal carcinogenesis [8-13], and there is a possibility that a strategy targeting intestinal microorganisms will be taken as future methods for preventing colorectal carcinogenesis. This review describes the prospects for new strategies on colorectal carcinogenesis prevention targeting intestinal microbiome such as F. nucleatum.
收稿日期:2021年1月03日;录用日期:2021年1月26日;据报道,所谓的清洁结肠手术,其中所有癌前病变,结肠管状腺瘤/结肠管状绒毛腺瘤,在内镜下切除治疗,对预防结直肠癌发生和结直肠癌死亡非常有用[1-4]。降糖药二甲双胍、小剂量阿司匹林等化学预防措施的有效性也有报道[5-7]。近年来,有报道表明肠内微生物如核梭杆菌(Fusobacterium nucleatum, F. nucleatum)参与结直肠癌的发生[8-13],未来有可能采取针对肠道微生物的策略来预防结直肠癌的发生。本文综述了针对具核梭菌等肠道微生物群的结直肠癌预防新策略的研究前景。
{"title":"Prospects for colorectal cancer prevention targeting intestinal microbiome","authors":"T. Ohara","doi":"10.15761/icst.1000351","DOIUrl":"https://doi.org/10.15761/icst.1000351","url":null,"abstract":"Received: January 03, 2021; Accepted: January 26, 2021; Published: January 29, 2021 It has been reported that a so-called clean colon procedure, in which all precancerous lesions, colorectal tubular adenomas / colorectal tubulovillous adenomas, are endoscopically resection treatment is extremely useful for preventing colorectal carcinogenesis and death from colorectal cancer [1-4]. The effectiveness of chemopreventive measures to take the antidiabetic drugs metformin and low-dose aspirin has also been reported [5-7]. Recently, there have been reports suggesting the involvement of intestinal microorganisms such as Fusobacterium nucleatum (F. nucleatum) in colorectal carcinogenesis [8-13], and there is a possibility that a strategy targeting intestinal microorganisms will be taken as future methods for preventing colorectal carcinogenesis. This review describes the prospects for new strategies on colorectal carcinogenesis prevention targeting intestinal microbiome such as F. nucleatum.","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytotherapy and oncology. A short review 植物疗法和肿瘤学。简短回顾
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000353
A. Sannia
{"title":"Phytotherapy and oncology. A short review","authors":"A. Sannia","doi":"10.15761/icst.1000353","DOIUrl":"https://doi.org/10.15761/icst.1000353","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"102 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compound cantharis revers chemotherapy resistance of TNBC via miR-520d/Beclin-1 signal axis 复方cantharis通过miR-520d/Beclin-1信号轴逆转TNBC化疗耐药
Pub Date : 2021-01-01 DOI: 10.15761/icst.1000354
Hong-chang Li, Huan Liu, Ya-feng Chen, Jie Li, Weiyan Liu, Ke-Bin Xu, D. Feng, Xia Sheng
{"title":"Compound cantharis revers chemotherapy resistance of TNBC via miR-520d/Beclin-1 signal axis","authors":"Hong-chang Li, Huan Liu, Ya-feng Chen, Jie Li, Weiyan Liu, Ke-Bin Xu, D. Feng, Xia Sheng","doi":"10.15761/icst.1000354","DOIUrl":"https://doi.org/10.15761/icst.1000354","url":null,"abstract":"","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67478572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Integrative cancer science and therapeutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1